1. IDDF2019-ABS-0134 Sofosbuvir/velpatasvir is effective and safe in patients with concomitant proton pump inhibitor use in clinical studies. (June 2019) Authors: Esteban, Rafael; Agarwal, Kosh; Calleja, Jose Luis; Dufour, Jean-Francois; Flamm, Steven; Gordon, Stuart; Stamm, Luisa; Ni, Liyun; Brainard, Diana; Sze Man Yip, Christina; Kowdley, Kris; Cooper, Curtis; Pineda, Juan Antonio; Castells, Lluis; Buti, Maria; Lens, Sabela Journal: Gut Issue: Volume 68(2019)Supplement 1 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗